PortfoliosLab logoPortfoliosLab logo
OCUL vs. ISSC
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

OCUL vs. ISSC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ocular Therapeutix, Inc. (OCUL) and Innovative Solutions and Support, Inc. (ISSC). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

OCUL vs. ISSC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
OCUL
Ocular Therapeutix, Inc.
-30.23%42.15%91.48%58.72%-59.68%-66.33%424.05%-0.75%-10.56%-46.83%
ISSC
Innovative Solutions and Support, Inc.
8.39%121.78%0.12%3.77%25.32%0.61%29.83%158.41%-23.13%-11.71%

Fundamentals

Market Cap

OCUL:

$1.89B

ISSC:

$370.84M

EPS

OCUL:

-$1.38

ISSC:

$1.05

PS Ratio

OCUL:

31.49

ISSC:

4.11

PB Ratio

OCUL:

2.89

ISSC:

5.39

Total Revenue (TTM)

OCUL:

$51.95M

ISSC:

$90.14M

Gross Profit (TTM)

OCUL:

$45.25M

ISSC:

$45.79M

EBITDA (TTM)

OCUL:

-$258.96M

ISSC:

$28.99M

Returns By Period

In the year-to-date period, OCUL achieves a -30.23% return, which is significantly lower than ISSC's 8.39% return. Over the past 10 years, OCUL has underperformed ISSC with an annualized return of -1.51%, while ISSC has yielded a comparatively higher 24.63% annualized return.


OCUL

1D
14.46%
1M
-5.26%
YTD
-30.23%
6M
-27.54%
1Y
15.55%
3Y*
17.14%
5Y*
-13.42%
10Y*
-1.51%

ISSC

1D
5.07%
1M
-20.86%
YTD
8.39%
6M
64.37%
1Y
226.39%
3Y*
40.90%
5Y*
26.61%
10Y*
24.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OCUL vs. ISSC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OCUL
OCUL Risk / Return Rank: 5050
Overall Rank
OCUL Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
OCUL Sortino Ratio Rank: 5353
Sortino Ratio Rank
OCUL Omega Ratio Rank: 5252
Omega Ratio Rank
OCUL Calmar Ratio Rank: 4747
Calmar Ratio Rank
OCUL Martin Ratio Rank: 4848
Martin Ratio Rank

ISSC
ISSC Risk / Return Rank: 9191
Overall Rank
ISSC Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
ISSC Sortino Ratio Rank: 9292
Sortino Ratio Rank
ISSC Omega Ratio Rank: 9292
Omega Ratio Rank
ISSC Calmar Ratio Rank: 8989
Calmar Ratio Rank
ISSC Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OCUL vs. ISSC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ocular Therapeutix, Inc. (OCUL) and Innovative Solutions and Support, Inc. (ISSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OCULISSCDifference

Sharpe ratio

Return per unit of total volatility

0.21

2.63

-2.42

Sortino ratio

Return per unit of downside risk

0.91

3.02

-2.11

Omega ratio

Gain probability vs. loss probability

1.11

1.42

-0.31

Calmar ratio

Return relative to maximum drawdown

0.20

3.73

-3.53

Martin ratio

Return relative to average drawdown

0.52

7.92

-7.40

OCUL vs. ISSC - Sharpe Ratio Comparison

The current OCUL Sharpe Ratio is 0.21, which is lower than the ISSC Sharpe Ratio of 2.63. The chart below compares the historical Sharpe Ratios of OCUL and ISSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


OCULISSCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.21

2.63

-2.42

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.17

0.47

-0.64

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.02

0.44

-0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

0.13

-0.18

Correlation

The correlation between OCUL and ISSC is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

OCUL vs. ISSC - Dividend Comparison

Neither OCUL nor ISSC has paid dividends to shareholders.


TTM202520242023202220212020
OCUL
Ocular Therapeutix, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ISSC
Innovative Solutions and Support, Inc.
0.00%0.00%0.00%0.00%0.01%0.00%17.64%

Drawdowns

OCUL vs. ISSC - Drawdown Comparison

The maximum OCUL drawdown since its inception was -95.19%, which is greater than ISSC's maximum drawdown of -89.03%. Use the drawdown chart below to compare losses from any high point for OCUL and ISSC.


Loading graphics...

Drawdown Indicators


OCULISSCDifference

Max Drawdown

Largest peak-to-trough decline

-95.19%

-89.03%

-6.16%

Max Drawdown (1Y)

Largest decline over 1 year

-57.29%

-57.83%

+0.54%

Max Drawdown (5Y)

Largest decline over 5 years

-89.14%

-57.83%

-31.31%

Max Drawdown (10Y)

Largest decline over 10 years

-90.94%

-62.41%

-28.53%

Current Drawdown

Current decline from peak

-80.43%

-32.82%

-47.61%

Average Drawdown

Average peak-to-trough decline

-76.58%

-50.71%

-25.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.71%

27.25%

-4.54%

Volatility

OCUL vs. ISSC - Volatility Comparison

The current volatility for Ocular Therapeutix, Inc. (OCUL) is 19.52%, while Innovative Solutions and Support, Inc. (ISSC) has a volatility of 28.90%. This indicates that OCUL experiences smaller price fluctuations and is considered to be less risky than ISSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


OCULISSCDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.52%

28.90%

-9.38%

Volatility (6M)

Calculated over the trailing 6-month period

58.02%

59.06%

-1.04%

Volatility (1Y)

Calculated over the trailing 1-year period

75.47%

86.80%

-11.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.73%

57.45%

+21.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.20%

56.25%

+23.95%

Financials

OCUL vs. ISSC - Financials Comparison

This section allows you to compare key financial metrics between Ocular Therapeutix, Inc. and Innovative Solutions and Support, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00M10.00M15.00M20.00M25.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
13.25M
21.81M
(OCUL) Total Revenue
(ISSC) Total Revenue
Values in USD except per share items